THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
< Back to front page Text size +

White House recognizes Quincy detective for Narcan program

Posted by Jessica Bartlett  October 12, 2012 03:30 PM

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Quincy’s Lieutenant Detective Patrick Glynn has received an award from White House Office of National Drug Control Policy for helping reduce substance abuse in the South Shore.

The 2012 “Advocate for Action” award recognizes those who have made strong contributions in reducing substance abuse across the nation, and with Glynn’s work in the Narcan program, he was a prime applicant.

“Because of Lt. Det. Glynn’s leadership, Quincy’s Narcan program has become a model across the country. This program saves lives and gives people a second chance at changing their futures for the better,” Mayor Thomas Koch said in a release.

Glynn has been a staunch advocate for wider adoption of the program after all Quincy officers were trained in 2010 to use Narcan for drug overdoses.

Administered nasally, the device knocks drug users off of their high by inhibiting the receptors in the brain that typically receive the drug’s chemicals.

The initiative was sponsored by Koch’s Substance Abuse Task Force, parent advocate groups, and Impact Quincy, a program of Bay State Community Services.

Since its inception, over 50 people have been saved using the program, the city says.

According to a release, the program bridges the gap between law enforcement and the general public, as officers are able to administer Narcan to bring a person out of an overdose. That person can then receive substance abuse intervention services.

The award letter to Glynn called his work an “example of how law enforcement and public health can partner to disrupt the cycle of drug abuse, crime and recidivism.”

Glynn will be honored at a ceremony in Washington, D.C., next spring.

More information on the city’s Narcan program is available here: www.quincyoverdosehelp.org.

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article